v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities    
Net loss $ (78,373) $ (71,433)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 7,110 11,618
Depreciation and amortization expense 208 208
Accretion of premium and discounts on marketable securities (1,123) (3,061)
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (39) 1,743
Other assets 88 (4,197)
Accounts payable (2,887) 4,386
Accrued expenses and other liabilities (8,354) (2,602)
Operating lease liabilities (105) (95)
Net cash used in operating activities (83,475) (63,433)
Cash flows from investing activities    
Purchases of marketable securities (108,356) (223,368)
Sales and maturities of marketable securities 172,409 324,266
Net cash provided by investing activities 64,053 100,898
Cash flows from financing activities    
Proceeds from issuance of common stock upon exercise of stock options 871  
Proceeds from issuance of common stock under employee stock purchase plan 132 138
Repurchase of common stock   (14,093)
Issuance of restricted stock units (746) (485)
Net cash provided by (used in) financing activities 257 (14,440)
Net (decrease) increase in cash and cash equivalents (19,165) 23,025
Cash and cash equivalents at the beginning of period 95,713 64,696
Cash and cash equivalents at the end of period $ 76,548 $ 87,721